The expansion, supported by a significant UK government grant, includes a new lipid system synthesis facility and enhanced R&D capabilities
Bictegravir, Emtricitabine, and Tenofovir Alafenamide Tablets are indicated for the treatment of human immunodeficiency virus infection in adults and pediatric patients weighing at least 25 kg
Ultra-high purity surfactant for biologics and parenteral drug formulations
Relonchem receives marketing authorization for Moxonidine tablets
Alkem's Pertuza is an affordable, indigenously-developed and manufactured biosimilar of pertuzumab
Prolia is a prescription medicine used to treat osteoporosis in women
The positive opinion is based on results from KOMET, the largest and only placebo-controlled, double-blind global Phase III trial in this patient population
The facility has been classified as Voluntary Action Indicated
Subscribe To Our Newsletter & Stay Updated
